MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,501 | -48.7% | 99,607 | +66.0% | 0.08% | -53.3% |
| Q1 2023 | $246,600 | -95.6% | 60,000 | -93.7% | 0.18% | -94.7% |
| Q4 2022 | $5,567,000 | -3.8% | 950,000 | +165.6% | 3.43% | +64.2% |
| Q1 2021 | $5,787,000 | -68.7% | 357,689 | -48.5% | 2.09% | -58.5% |
| Q4 2020 | $18,467,000 | +48.6% | 694,000 | +4.0% | 5.02% | +48.9% |
| Q3 2020 | $12,429,000 | -16.0% | 667,500 | +5.5% | 3.38% | -21.1% |
| Q2 2020 | $14,801,000 | +206.8% | 632,500 | -23.6% | 4.28% | +82.9% |
| Q1 2020 | $4,824,000 | – | 827,500 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |